Oramed Pharmaceuticals Inc. (ORMP) Social Stream
Oramed Pharmaceuticals Inc (ORMP) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Oramed Pharmaceuticals Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ORMP's average price target has moved up $8 over the prior 29 weeks.
ORMP reports an average of 85.16% for its upside potential over the past 51 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ORMP Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
ORMP's average broker recommendation rating improved by 0 over the prior 21 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ORMP has a greater upside potential (average analyst target price relative to current price) than 544.11% of all US stocks.
- In terms of how Oramed Pharmaceuticals Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than 90.66% of that group.
- In terms of how Oramed Pharmaceuticals Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -275.03% of that group.
- Oramed Pharmaceuticals Inc's average analyst price target is higher than 414.06% of stocks in the small market cap category.
In the Pharmaceutical Products industry, ORIC, OPTN, and ONTX are the three stocks most similar to Oramed Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
What is the outlook for ORMP? Use POWR Ratings for clearer insight into price direction.